via University of Pittsburgh School of Medicine
Today in Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to prevent and treat COVID-19.
These special llama antibodies, called “nanobodies,” are much smaller than human antibodies and many times more effective at neutralizing the SARS-CoV-2 virus. They’re also much more stable.
“Nature is our best inventor,” said senior author Yi Shi, Ph.D., assistant professor of cell biology at Pitt. “The technology we developed surveys SARS-CoV-2 neutralizing nanobodies at an unprecedented scale, which allowed us to quickly discover thousands of nanobodies with unrivaled affinity and specificity.”
To generate these nanobodies, Shi turned to a black llama named Wally—who resembles and therefore shares his moniker with Shi’s black Labrador.
Shi and colleagues immunized the llama with a piece of the SARS-CoV-2 spike protein and, after about two months, the animal’s immune system produced mature nanobodies against the virus.
Using a mass spectrometry-based technique that Shi has been perfecting for the past three years, lead author Yufei Xiang, a research assistant in Shi’s lab, identified the nanobodies in Wally’s blood that bind to SARS-CoV-2 most strongly.
Then, with the help of Pitt’s Center for Vaccine Research (CVR), the scientists exposed their nanobodies to live SARS-CoV-2 virus and found that just a fraction of a nanogram could neutralize enough virus to spare a million cells from being infected.
These nanobodies represent some of the most effective therapeutic antibody candidates for SARS-CoV-2, hundreds to thousands of times more effective than other llama nanobodies discovered through the same phage display methods used for decades to fish for human monoclonal antibodies.
Shi’s nanobodies can sit at room temperature for six weeks and tolerate being fashioned into an inhalable mist to deliver antiviral therapy directly into the lungs where they’re most needed. Since SARS-CoV-2 is a respiratory virus, the nanobodies could find and latch onto it in the respiratory system, before it even has a chance to do damage.
In contrast, traditional SARS-CoV-2 antibodies require an IV, which dilutes the product throughout the body, necessitating a much larger dose and costing patients and insurers around $100,000 per treatment course.
“Nanobodies could potentially cost much less,” said Shi. “They’re ideal for addressing the urgency and magnitude of the current crisis.”
In collaboration with Cheng Zhang, Ph.D., at Pitt, and Dina Schneidman-Duhovny, Ph.D., at the Hebrew University of Jerusalem, the team found that their nanobodies use a variety of mechanisms to block SARS-CoV-2 infection. This makes nanobodies ripe for bioengineering. For instance, nanobodies that bind to different regions on the SARS-CoV-2 virus can be linked together, like a Swiss army knife, in case one part of the virus mutates and becomes drug-resistant.
“As a virologist, it’s incredible to see how harnessing the quirkiness of llama antibody generation can be translated into the creation of a potent nanoweapon against clinical isolates of SARS-CoV-2,” said study coauthor and CVR Director Paul Duprex, Ph.D.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Llama nanobodies
- Mental Health during COVID-19: Top Tips to Manage COVID Anxiety, Depression - Latest News and Research Updates
Coping with mental health during COVID-19 is the need of the hour. The article highlights top tips to manage mental health and well-being during the pandemic.
- Super-immunity in a camelid extensively immunized with the SARS-CoV-2 receptor-binding domain
Nanobodies (Nbs) are small ... and a broad range of sarbecoviruses. First, a llama was immunized with a recombinant SARS-CoV-2 RBD, fused with the fragment crystallizable (Fc) region of human ...
- Nanobodies News and Research
In "proof of concept" experiments with mouse and human cells and tissues, Johns Hopkins Medicine researchers say they have designed tiny proteins, called nanobodies, derived from llama antibodies ...
- The Immune System – News and Features
Dr. Yi Shi, assistant professor in the department of cell biology at the University of Pittsburgh and colleagues are exploring the potential of nanobodies as a treatment ... a 'nanobody' – a small ...
- News tagged with cancerous cells
In "proof of concept" experiments with mouse and human cells and tissues, Johns Hopkins Medicine researchers say they have designed tiny proteins, called nanobodies, derived from llama antibodies ...
Go deeper with Google Headlines on:
Llama nanobodies
Go deeper with Bing News on:
Inhalable therapeutics to prevent and treat COVID-19
- Trends are shifting, but COVID-19 and its effects are still not equitable
"Even though we've closed some of the large disparities we saw early on, there are still continued disparities in several areas," said Dr. Sarita Shah, a clinical care provider and infectious disease ...
- Professor of medicine says no need to panic over COVID-19 reinfection
An expert says Canadians don’t need to panic about COVID-19 reinfections even as Prime Minister Justin Trudeau has tested positive a second time for the virus. Stephen Hoption Cann, a clinical ...
- What you need to know about access to COVID antiviral drugs and therapeutics in WA
As infection and hospitalization numbers continue to rise, one question, doctors say, is becoming more common: If you test positive for COVID-19, what treatments are you eligible for?
- Prevention techniques, treatment helping keep COVID-19 numbers down statewide
May 30—COVID-19 continues to spread across Washington, and quickly. But with prevention techniques like masking, treatment like Paxlovid, and vaccines and boosters, health officials are not concerned ...
- Goconnect Limited (NSX:GO8) COVIRIX Medical And Diacarta Inc Partnership
COVIRIX Medical has applied to the Australian Therapeutics Goods Administration ... profile to be delivered in an inhalable form, to prevent and treat the COVID-19 virus irrespective of the ...